These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 15670063)
1. Bbeta 14 Arg --> Cys variant dysfibrinogen and its association with thrombosis. Castaman G; Ghiotto R; Tosetto A; Rodeghiero F J Thromb Haemost; 2005 Feb; 3(2):409-10. PubMed ID: 15670063 [No Abstract] [Full Text] [Related]
2. Fibrinogen Darlinghurst: hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications. Sheen CR; Low J; Joseph J; Kotlyar E; George PM; Brennan SO Thromb Haemost; 2006 Nov; 96(5):685-7. PubMed ID: 17080227 [No Abstract] [Full Text] [Related]
3. Three cases of abnormal fibrinogens: sumperk (Bbeta His67Leu), Unicov (Bbeta Gly414Ser), and Brno (gammaArg275His). Kotlín R; Reicheltová Z; Sobotková A; Suttnar J; Salaj P; Pospísilová D; Smejkal P; Chrastinová L; Dyr JE Thromb Haemost; 2008 Dec; 100(6):1199-200. PubMed ID: 19132250 [No Abstract] [Full Text] [Related]
4. Paradoxical bleeding and thrombosis in a patient with afibrinogenemia and fibrinogen Mumbai mutation. Mukaddam A; Patil R; Jadli A; Chandrakala S; Ghosh K; Shetty S Am J Clin Pathol; 2015 May; 143(5):755-7. PubMed ID: 25873512 [TBL] [Abstract][Full Text] [Related]
5. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications. Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352 [TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Tolaga Bay: a novel gammaAla341Val mutation causing hypofibrinogenaemia. Davis RL; Brennan SO Thromb Haemost; 2007 Nov; 98(5):1136-8. PubMed ID: 18000621 [No Abstract] [Full Text] [Related]
7. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations. Castaman G; Giacomelli SH; Duga S; Rodeghiero F Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984 [No Abstract] [Full Text] [Related]
8. Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a gamma320Asp deletion at the Ca2+ binding site. Brennan SO; Davis RL; Mosesson MW; Hernandez I; Lowen R; Alexander SJ Thromb Haemost; 2007 Aug; 98(2):467-9. PubMed ID: 17721633 [No Abstract] [Full Text] [Related]
9. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Haverkate F; Samama M Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487 [TBL] [Abstract][Full Text] [Related]
10. Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias: Barcelona III and IV (gamma Arg 275-->His) and Villajoyosa (gamma Arg 275-->Cys). Borrell M; Garí M; Coll I; Vallvé C; Tirado I; Soria JM; Sala N; Muñoz C; Oliver A; García A Blood Coagul Fibrinolysis; 1995 May; 6(3):198-206. PubMed ID: 7654933 [TBL] [Abstract][Full Text] [Related]
11. Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bbeta-chain gene. Monaldini L; Asselta R; Duga S; Peyvandi F; Ghosh K; Malcovati M; Tenchini ML Haematologica; 2006 May; 91(5):628-33. PubMed ID: 16670068 [TBL] [Abstract][Full Text] [Related]
12. Congenital fibrinogen disorders with repeated thrombosis. Zhang X; Zhang C; Wang B; Chen N; Sun G; Guo X J Thromb Thrombolysis; 2020 Feb; 49(2):312-315. PubMed ID: 31542854 [TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release. Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754 [TBL] [Abstract][Full Text] [Related]
14. Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation. Berens C; Rühl H; Ivaškevičius V; Oldenburg J; Hertfelder HJ; Pötzsch B Thromb Haemost; 2016 May; 115(5):1073-5. PubMed ID: 26763372 [No Abstract] [Full Text] [Related]
16. Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias. Hill M; Dolan G Haemophilia; 2008 Sep; 14(5):889-97. PubMed ID: 18564189 [TBL] [Abstract][Full Text] [Related]
17. Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations. Brennan SO; Fellowes AP; Faed JM; George PM Blood; 2000 Mar; 95(5):1709-13. PubMed ID: 10688828 [TBL] [Abstract][Full Text] [Related]
18. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders. Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337 [TBL] [Abstract][Full Text] [Related]
19. Deletion of five residues from the coiled coil of fibrinogen (Bbeta Asn167_Glu171del) associated with bleeding and hypodysfibrinogenemia. Brennan SO; Davis RL; Lowen R; Ruskova A Haematologica; 2009 Apr; 94(4):585-8. PubMed ID: 19229055 [TBL] [Abstract][Full Text] [Related]